SERA |
SERA PROGNOSTICS, INC. |
Feb 12, 2025 |
0 |
$0 |
3 |
Feb 14, 2025 |
10%+ Owner |
BCYC |
BICYCLE THERAPEUTICS PLC |
Jan 2, 2025 |
4 |
$0 |
4 |
Jan 6, 2025 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Dec 31, 2024 |
2 |
$0 |
4 |
Jan 3, 2025 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Dec 31, 2024 |
2 |
$0 |
4 |
Jan 3, 2025 |
Director, 10%+ Owner |
KALA |
KALA BIO, Inc. |
Dec 30, 2024 |
2 |
$2M |
4 |
Dec 31, 2024 |
10%+ Owner |
BCYC |
BICYCLE THERAPEUTICS PLC |
Dec 13, 2024 |
10 |
$21.2M |
4 |
Dec 17, 2024 |
Director, 10%+ Owner |
BGNE |
BeiGene, Ltd. |
Dec 9, 2024 |
4 |
-$194M |
4 |
Dec 10, 2024 |
Director |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Oct 4, 2024 |
4 |
$0 |
4 |
Oct 8, 2024 |
Director |
IGMS |
IGM Biosciences, Inc. |
Sep 30, 2024 |
2 |
$0 |
4 |
Oct 2, 2024 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Sep 30, 2024 |
2 |
$0 |
4 |
Oct 2, 2024 |
Director, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Aug 20, 2024 |
3 |
$106M |
4 |
Aug 22, 2024 |
Director |
IGMS |
IGM Biosciences, Inc. |
Jun 28, 2024 |
2 |
$0 |
4 |
Jul 2, 2024 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Jun 28, 2024 |
2 |
$0 |
4 |
Jul 2, 2024 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jun 28, 2024 |
2 |
$0 |
4 |
Jul 2, 2024 |
Director, 10%+ Owner |
KALA |
KALA BIO, Inc. |
Jun 28, 2024 |
0 |
$0 |
3 |
Jun 28, 2024 |
10%+ Owner |
VTVT |
vTv Therapeutics Inc. |
Jun 25, 2024 |
4 |
$0 |
4 |
Jun 27, 2024 |
Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jun 25, 2024 |
4 |
$0 |
4 |
Jun 27, 2024 |
Director |
TRDA |
Entrada Therapeutics, Inc. |
Jun 25, 2024 |
2 |
$50M |
4 |
Jun 26, 2024 |
10%+ Owner |
BCYC |
BICYCLE THERAPEUTICS PLC |
Jun 17, 2024 |
4 |
$0 |
4 |
Jun 20, 2024 |
Director, 10%+ Owner |
PRLD |
Prelude Therapeutics Inc |
Jun 14, 2024 |
2 |
$0 |
4 |
Jun 18, 2024 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Jun 12, 2024 |
6 |
-$328M |
4 |
Jun 14, 2024 |
Director, 10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Jun 12, 2024 |
2 |
$0 |
4 |
Jun 14, 2024 |
Director |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 5, 2024 |
4 |
$0 |
4 |
Jun 7, 2024 |
Director |
BGNE |
BeiGene, Ltd. |
Jun 5, 2024 |
4 |
$0 |
4 |
Jun 7, 2024 |
Director, 10%+ Owner |
ACAD |
ACADIA PHARMACEUTICALS INC |
May 29, 2024 |
4 |
$0 |
4 |
May 31, 2024 |
Director, 10%+ Owner |
BCYC |
BICYCLE THERAPEUTICS plc |
May 29, 2024 |
2 |
$367M |
4 |
May 29, 2024 |
Director, 10%+ Owner |
IMCR |
Immunocore Holdings plc |
May 28, 2024 |
2 |
$0 |
4 |
May 29, 2024 |
Director |
IMCR |
Immunocore Holdings plc |
May 28, 2024 |
0 |
$0 |
3 |
May 29, 2024 |
Director |
INCY |
INCYTE CORP |
May 7, 2024 |
4 |
$1.47M |
4 |
May 9, 2024 |
Director, 10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Apr 19, 2024 |
2 |
$69M |
4 |
Apr 23, 2024 |
Director |
BCYC |
BICYCLE THERAPEUTICS plc |
Apr 18, 2024 |
4 |
$0 |
4 |
Apr 22, 2024 |
Director, 10%+ Owner |
BCYC |
BICYCLE THERAPEUTICS plc |
Apr 18, 2024 |
0 |
$0 |
3 |
Apr 18, 2024 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Mar 29, 2024 |
2 |
$0 |
4 |
Apr 1, 2024 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Mar 28, 2024 |
2 |
$0 |
4 |
Apr 1, 2024 |
Director, 10%+ Owner |
KYMR |
Kymera Therapeutics, Inc. |
Mar 28, 2024 |
2 |
$0 |
4 |
Apr 1, 2024 |
Director |
KYMR |
Kymera Therapeutics, Inc. |
Mar 28, 2024 |
0 |
$0 |
3 |
Apr 1, 2024 |
Director |
IGMS |
IGM Biosciences, Inc. |
Mar 26, 2024 |
8 |
$3.43M |
4 |
Mar 28, 2024 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Mar 21, 2024 |
2 |
$275M |
4 |
Mar 25, 2024 |
Director |
IGMS |
IGM Biosciences, Inc. |
Mar 12, 2024 |
2 |
$0 |
4 |
Mar 14, 2024 |
Director, 10%+ Owner |
VTVT |
vTv Therapeutics Inc. |
Mar 5, 2024 |
4 |
$0 |
4 |
Mar 7, 2024 |
Director |
VTVT |
vTv Therapeutics Inc. |
Feb 27, 2024 |
0 |
$0 |
3 |
Mar 7, 2024 |
Director |
IGMS |
IGM Biosciences, Inc. |
Dec 29, 2023 |
2 |
$0 |
4 |
Jan 3, 2024 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Dec 29, 2023 |
2 |
$0 |
4 |
Jan 3, 2024 |
Director, 10%+ Owner |
NGNE |
Neurogene Inc. |
Dec 18, 2023 |
8 |
$0 |
4 |
Dec 20, 2023 |
Director, Former 10% Owner |
SGEN |
Seagen Inc. |
Dec 14, 2023 |
13 |
-$10.2B |
4 |
Dec 18, 2023 |
Director, Former 10% Owner |
IGMS |
IGM Biosciences, Inc. |
Dec 13, 2023 |
12 |
$3.43M |
4 |
Dec 15, 2023 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Dec 13, 2023 |
24 |
$22.5M |
4 |
Dec 14, 2023 |
Director |
PRLD |
Prelude Therapeutics Inc |
Dec 13, 2023 |
2 |
$25M |
4 |
Dec 13, 2023 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Dec 12, 2023 |
30 |
$7.55M |
4 |
Dec 14, 2023 |
Director |
BLCM |
BELLICUM PHARMACEUTICALS, INC |
Nov 22, 2023 |
4 |
$212 |
4 |
Nov 24, 2023 |
10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Nov 21, 2023 |
20 |
$12.1M |
4 |
Nov 21, 2023 |
Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Nov 17, 2023 |
30 |
$11.9M |
4 |
Nov 21, 2023 |
Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Nov 14, 2023 |
4 |
$7.81M |
4 |
Nov 15, 2023 |
Director |
BGNE |
BeiGene, Ltd. |
Nov 14, 2023 |
2 |
-$199M |
4 |
Nov 14, 2023 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Nov 13, 2023 |
30 |
$15.8M |
4 |
Nov 15, 2023 |
Director |
BCEL |
Atreca, Inc. |
Oct 19, 2023 |
2 |
-$111K |
4 |
Oct 23, 2023 |
Former 10% Owner |
NLTX |
Neoleukin Therapeutics, Inc. |
Oct 5, 2023 |
4 |
$0 |
4 |
Oct 10, 2023 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Oct 3, 2023 |
2 |
$250M |
4 |
Oct 5, 2023 |
Director |
IGMS |
IGM Biosciences, Inc. |
Sep 29, 2023 |
2 |
$0 |
4 |
Oct 3, 2023 |
Director |
INCY |
INCYTE CORP |
Sep 29, 2023 |
2 |
$0 |
4 |
Oct 3, 2023 |
Director, 10%+ Owner |
NLTX |
Neoleukin Therapeutics, Inc. |
Aug 15, 2023 |
12 |
$1.46M |
4 |
Aug 17, 2023 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jun 30, 2023 |
2 |
$0 |
4 |
Jul 5, 2023 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Jun 30, 2023 |
2 |
$0 |
4 |
Jul 5, 2023 |
Director |
INCY |
INCYTE CORP |
Jun 30, 2023 |
2 |
$0 |
4 |
Jul 5, 2023 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Jun 26, 2023 |
2 |
$45M |
4 |
Jun 28, 2023 |
Director |
PRLD |
Prelude Therapeutics Inc |
Jun 16, 2023 |
2 |
$0 |
4 |
Jun 21, 2023 |
Director, 10%+ Owner |
BGNE |
BeiGene, Ltd. |
Jun 15, 2023 |
4 |
$0 |
4 |
Jun 20, 2023 |
Director, 10%+ Owner |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jun 15, 2023 |
2 |
$0 |
4 |
Jun 20, 2023 |
Director |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Jun 15, 2023 |
0 |
$0 |
3 |
Jun 20, 2023 |
Director |
INCY |
INCYTE CORP |
Jun 14, 2023 |
4 |
$0 |
4 |
Jun 16, 2023 |
Director, 10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Jun 13, 2023 |
2 |
$0 |
4 |
Jun 15, 2023 |
Director |
TLIS |
Talis Biomedical Corp |
Jun 9, 2023 |
2 |
$0 |
4 |
Jun 13, 2023 |
Director, 10%+ Owner |
NLTX |
Neoleukin Therapeutics, Inc. |
Jun 8, 2023 |
2 |
$0 |
4 |
Jun 12, 2023 |
Director |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 6, 2023 |
4 |
$0 |
4 |
Jun 8, 2023 |
Director |
ACAD |
ACADIA PHARMACEUTICALS INC |
Jun 1, 2023 |
3 |
$0 |
4 |
Jun 5, 2023 |
Director, 10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Jun 1, 2023 |
2 |
$75M |
4 |
Jun 2, 2023 |
Director |
SGEN |
Seagen Inc. |
May 31, 2023 |
2 |
$0 |
4 |
Jun 2, 2023 |
Director, 10%+ Owner |
ACAD |
ACADIA PHARMACEUTICALS INC |
May 22, 2023 |
18 |
$23.1M |
4 |
May 24, 2023 |
Director, 10%+ Owner |
PRLD |
Prelude Therapeutics Inc |
May 22, 2023 |
4 |
$75M |
4 |
May 24, 2023 |
Director, 10%+ Owner |
BLCM |
BELLICUM PHARMACEUTICALS, INC |
May 5, 2023 |
0 |
$0 |
3 |
May 5, 2023 |
10%+ Owner |
SGEN |
Seagen Inc. |
May 1, 2023 |
9 |
$642K |
4 |
May 3, 2023 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Apr 4, 2023 |
1 |
$0 |
4 |
Apr 6, 2023 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Mar 31, 2023 |
2 |
$0 |
4 |
Apr 4, 2023 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Mar 31, 2023 |
2 |
$0 |
4 |
Apr 4, 2023 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Mar 13, 2023 |
4 |
$910K |
4 |
Mar 15, 2023 |
Director, 10%+ Owner |
ACAD |
ACADIA PHARMACEUTICALS INC |
Jan 12, 2023 |
4 |
$157K |
4 |
Jan 17, 2023 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Dec 30, 2022 |
2 |
$0 |
4 |
Jan 4, 2023 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Sep 30, 2022 |
2 |
$0 |
4 |
Oct 4, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jun 30, 2022 |
1 |
$0 |
4 |
Jul 5, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Jun 30, 2022 |
2 |
$0 |
4 |
Jul 1, 2022 |
Director, 10%+ Owner |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 29, 2022 |
3 |
$0 |
4 |
Jun 30, 2022 |
Director |
BGNE |
BeiGene, Ltd. |
Jun 22, 2022 |
3 |
$0 |
4 |
Jun 24, 2022 |
Director, 10%+ Owner |
PRLD |
Prelude Therapeutics Inc |
Jun 17, 2022 |
1 |
$0 |
4 |
Jun 22, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Jun 15, 2022 |
3 |
$0 |
4 |
Jun 17, 2022 |
Director, 10%+ Owner |
DBVT |
DBV Technologies S.A. |
Jun 13, 2022 |
4 |
$0 |
4 |
Jun 13, 2022 |
Director, 10%+ Owner |
TLIS |
Talis Biomedical Corp |
Jun 10, 2022 |
1 |
$0 |
4 |
Jun 13, 2022 |
Director, 10%+ Owner |
ACAD |
ACADIA PHARMACEUTICALS INC |
Jun 7, 2022 |
3 |
$0 |
4 |
Jun 9, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jun 2, 2022 |
12 |
$4.45M |
4 |
Jun 6, 2022 |
Director, 10%+ Owner |
TRDA |
Entrada Therapeutics, Inc. |
Jun 2, 2022 |
6 |
$261K |
4 |
Jun 6, 2022 |
10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Jun 1, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
May 25, 2022 |
16 |
$2.36M |
4 |
May 27, 2022 |
Director, 10%+ Owner |
TRDA |
Entrada Therapeutics, Inc. |
May 20, 2022 |
10 |
$282K |
4 |
May 24, 2022 |
10%+ Owner |
TRDA |
Entrada Therapeutics, Inc. |
May 16, 2022 |
8 |
$431K |
4 |
May 18, 2022 |
10%+ Owner |
KOD |
Kodiak Sciences Inc. |
May 16, 2022 |
14 |
$2.7M |
4 |
May 18, 2022 |
Director, 10%+ Owner |
SGEN |
Seagen Inc. |
May 13, 2022 |
3 |
$0 |
4 |
May 17, 2022 |
Director, 10%+ Owner |
NLTX |
Neoleukin Therapeutics, Inc. |
May 12, 2022 |
1 |
$0 |
4 |
May 16, 2022 |
Director |
TCRX |
TScan Therapeutics, Inc. |
May 10, 2022 |
8 |
$2.56M |
4 |
May 12, 2022 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Apr 1, 2022 |
2 |
$65M |
4 |
Apr 5, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Mar 31, 2022 |
2 |
$0 |
4 |
Apr 4, 2022 |
Director, 10%+ Owner |
IGMS |
IGM Biosciences, Inc. |
Mar 12, 2022 |
1 |
$0 |
4 |
Mar 15, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Mar 8, 2022 |
14 |
$29M |
4 |
Mar 10, 2022 |
Director, 10%+ Owner |
SGEN |
Seagen Inc. |
Mar 8, 2022 |
4 |
$702K |
4 |
Mar 10, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Feb 17, 2022 |
8 |
$35.7M |
4 |
Feb 22, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Feb 15, 2022 |
10 |
$21.8M |
4 |
Feb 17, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Feb 10, 2022 |
7 |
$107M |
4 |
Feb 14, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jan 27, 2022 |
12 |
$18.1M |
4 |
Jan 31, 2022 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Jan 21, 2022 |
10 |
$28.8M |
4 |
Jan 25, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Dec 31, 2021 |
2 |
$0 |
4 |
Jan 4, 2022 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Dec 15, 2021 |
10 |
$116M |
4 |
Dec 17, 2021 |
Director, 10%+ Owner |
TRDA |
Entrada Therapeutics, Inc. |
Dec 14, 2021 |
0 |
$0 |
3 |
Dec 16, 2021 |
10%+ Owner |
SGEN |
Seagen Inc. |
Nov 30, 2021 |
20 |
-$63.4M |
4 |
Dec 2, 2021 |
Director, 10%+ Owner |
TLIS |
Talis Biomedical Corp |
Nov 18, 2021 |
1 |
$218K |
4 |
Nov 19, 2021 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Sep 30, 2021 |
2 |
$0 |
4 |
Oct 4, 2021 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Sep 29, 2021 |
7 |
$8.33M |
4 |
Oct 1, 2021 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Sep 15, 2021 |
3 |
$3.01M |
4 |
Sep 17, 2021 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Sep 7, 2021 |
2 |
$5.37M |
4 |
Sep 9, 2021 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Aug 17, 2021 |
10 |
$10M |
4 |
Aug 19, 2021 |
Director, 10%+ Owner |
KOD |
Kodiak Sciences Inc. |
Aug 11, 2021 |
10 |
$8.96M |
4 |
Aug 13, 2021 |
Director, 10%+ Owner |
TCRX |
TScan Therapeutics, Inc. |
Jul 20, 2021 |
6 |
$21.4M |
4 |
Jul 22, 2021 |
Director |
TCRX |
TScan Therapeutics, Inc. |
Jul 15, 2021 |
0 |
$0 |
3 |
Jul 15, 2021 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
Jun 30, 2021 |
2 |
$0 |
4 |
Jul 2, 2021 |
Director, 10%+ Owner |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 29, 2021 |
1 |
$0 |
4 |
Jul 1, 2021 |
Director |
KOD |
Kodiak Sciences Inc. |
Jun 28, 2021 |
14 |
$23.7M |
4 |
Jun 30, 2021 |
Director, 10%+ Owner |
ACAD |
ACADIA PHARMACEUTICALS INC |
Jun 22, 2021 |
3 |
$0 |
4 |
Jun 24, 2021 |
Director, 10%+ Owner |
PRLD |
Prelude Therapeutics Inc |
Jun 18, 2021 |
1 |
$0 |
4 |
Jun 22, 2021 |
Director, 10%+ Owner |
BGNE |
BeiGene, Ltd. |
Jun 16, 2021 |
3 |
$0 |
4 |
Jun 21, 2021 |
Director, 10%+ Owner |
AGLE |
Aeglea BioTherapeutics, Inc. |
Jun 8, 2021 |
1 |
$0 |
4 |
Jun 10, 2021 |
Director |
INCY |
INCYTE CORP |
May 26, 2021 |
3 |
$0 |
4 |
May 28, 2021 |
Director, 10%+ Owner |
INCY |
INCYTE CORP |
May 14, 2021 |
4 |
$759K |
4 |
May 18, 2021 |
Director, 10%+ Owner |
SGEN |
Seagen Inc. |
May 14, 2021 |
7 |
$666K |
4 |
May 18, 2021 |
Director, 10%+ Owner |
NLTX |
Neoleukin Therapeutics, Inc. |
May 11, 2021 |
1 |
$0 |
4 |
May 13, 2021 |
Director |